A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Deficiencia de G-6-PD; Anemia hemolítica a causa de deficiencia de G-6-PD; Anemia hemolítica debido a deficiencia de G-6-PD
El tratamiento puede involucrar:
El desenlace clínico usual es la recuperación espontánea de un episodio hemolítico.
En raras ocasiones, se puede producir insuficiencia renal o la muerte después de un evento hemolítico severo.
Solicite una cita con el médico si presentan síntomas de esta afección.
Consulte con el médico si le han diagnosticado deficiencia de glucosa-6-fosfato deshidrogenasa y los síntomas no desaparecen después del tratamiento.
Gregg XT, Prchal JT. Red blood cell enzymopathies. In: Hoffman R, Benz Jr. EJ, Shattil SJ, et al., eds. Hematology: Basic Principles and Practice. 5th ed. Philadelphia, Pa: Churchill Livingston; 2008:chap 45.
Golan DER. Hemolytic anemias: red cell membrane and metabolic defects. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 165.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885